Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook
Elevance Health Inc. (NYSE:ELV) on Tuesday reported first-quarter 2025 revenues of $48.77 billion, up 15% year-over-year, higher than the consensus of $46.29 billion. The increase was driven by higher premium yields in the Health Benefits segment, acquisitions completed in the past year, Medicare Advantage and Individual ACA membership growth, and CarelonRx product revenue, partially offset by membership attrition in Medicaid business. Also Read: Health Insurers Surge After Medicare Agency Incre